Table of Contents 1 Angiogenesis Modulators Market Overview 1.1 Angiogenesis Modulators Product Overview 1.2 Angiogenesis Modulators Market Segment by Type 1.2.1 Angiogenesis Inhibitors 1.2.2 Angiogenesis Stimulators 1.2.3 Angiogenin 1.2.4 Others 1.3 Global Angiogenesis Modulators Market Size by Type 1.3.1 Global Angiogenesis Modulators Sales and Growth by Type 1.3.2 Global Angiogenesis Modulators Sales and Market Share by Type (2014-2019) 1.3.3 Global Angiogenesis Modulators Revenue and Market Share by Type (2014-2019) 1.3.4 Global Angiogenesis Modulators Price by Type (2014-2019) 2 Global Angiogenesis Modulators Market Competition by Company 2.1 Global Angiogenesis Modulators Sales and Market Share by Company (2014-2019) 2.2 Global Angiogenesis Modulators Revenue and Share by Company (2014-2019) 2.3 Global Angiogenesis Modulators Price by Company (2014-2019) 2.4 Global Top Players Angiogenesis Modulators Manufacturing Base Distribution, Sales Area, Product Types 2.5 Angiogenesis Modulators Market Competitive Situation and Trends 2.5.1 Angiogenesis Modulators Market Concentration Rate 2.5.2 Global Angiogenesis Modulators Market Share of Top 5 and Top 10 Players 2.5.3 Mergers & Acquisitions, Expansion 3 Angiogenesis Modulators Company Profiles and Sales Data 3.1 Celgene Corporation (USA) 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Angiogenesis Modulators Product Category, Application and Specification 3.1.3 Celgene Corporation (USA) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin(2014-2019) 3.1.4 Main Business Overview 3.2 Eisai Co., Ltd. (Japan) 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Angiogenesis Modulators Product Category, Application and Specification 3.2.3 Eisai Co., Ltd. (Japan) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin(2014-2019) 3.2.4 Main Business Overview 3.3 Amgen, Inc. (USA) 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Angiogenesis Modulators Product Category, Application and Specification 3.3.3 Amgen, Inc. (USA) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin(2014-2019) 3.3.4 Main Business Overview 3.4 Genentech, Inc. (USA) 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Angiogenesis Modulators Product Category, Application and Specification 3.4.3 Genentech, Inc. (USA) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin(2014-2019) 3.4.4 Main Business Overview 3.5 GlaxoSmithKline plc (UK) 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Angiogenesis Modulators Product Category, Application and Specification 3.5.3 GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin(2014-2019) 3.5.4 Main Business Overview 3.6 Bayer Pharma AG (Germany) 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Angiogenesis Modulators Product Category, Application and Specification 3.6.3 Bayer Pharma AG (Germany) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin(2014-2019) 3.6.4 Main Business Overview 3.7 Bionomics Ltd. (Australia) 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Angiogenesis Modulators Product Category, Application and Specification 3.7.3 Bionomics Ltd. (Australia) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin(2014-2019) 3.7.4 Main Business Overview 3.8 CASI Pharmaceuticals, Inc. (USA) 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Angiogenesis Modulators Product Category, Application and Specification 3.8.3 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin(2014-2019) 3.8.4 Main Business Overview 3.9 AstraZeneca plc (UK) 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Angiogenesis Modulators Product Category, Application and Specification 3.9.3 AstraZeneca plc (UK) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin(2014-2019) 3.9.4 Main Business Overview 3.10 Eli Lilly and Company (USA) 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Angiogenesis Modulators Product Category, Application and Specification 3.10.3 Eli Lilly and Company (USA) Angiogenesis Modulators Sales, Revenue, Price and Gross Margin(2014-2019) 3.10.4 Main Business Overview 3.11 F.Hoffmann-La Roche AG (Switzerland) 4 Angiogenesis Modulators Market Status and Outlook by Regions 4.1 Global Market Status and Outlook by Regions 4.1.1 Global Angiogenesis Modulators Market Size and CAGR by Regions 4.1.2 North America 4.1.3 Asia-Pacific 4.1.4 Europe 4.1.5 South America 4.1.6 Middle East and Africa 4.2 Global Angiogenesis Modulators Sales and Revenue by Regions 4.2.1 Global Angiogenesis Modulators Sales and Market Share by Regions (2014-2019) 4.2.2 Global Angiogenesis Modulators Revenue and Market Share by Regions (2014-2019) 4.2.3 Global Angiogenesis Modulators Sales, Revenue, Price and Gross Margin (2014-2019) 4.3 North America Angiogenesis Modulators Sales, Revenue, Price and Gross Margin 4.3.1 United States 4.3.2 Canada 4.3.3 Mexico 4.4 Europe Angiogenesis Modulators Sales, Revenue, Price and Gross Margin 4.4.1 Germany 4.4.2 UK 4.4.3 France 4.4.4 Italy 4.4.5 Russia 4.4.6 Turkey 4.5 Asia-Pacific Angiogenesis Modulators Sales, Revenue, Price and Gross Margin 4.5.1 China 4.5.2 Japan 4.5.3 Korea 4.5.4 Southeast Asia 4.5.4.1 Indonesia 4.5.4.2 Thailand 4.5.4.3 Malaysia 4.5.4.4 Philippines 4.5.4.5 Vietnam 4.5.5 India 4.5.6 Australia 4.6 South America Angiogenesis Modulators Sales, Revenue, Price and Gross Margin 4.6.1 Brazil 4.7 Middle East and Africa Angiogenesis Modulators Sales, Revenue, Price and Gross Margin 4.7.1 Egypt 4.7.2 GCC Countries 5 Angiogenesis Modulators Application/End Users 5.1 Angiogenesis Modulators Segment by Application 5.1.1 Breast Cancer 5.1.2 Colorectal Cancer 5.1.3 Lung Cancer 5.1.4 Prostate Cancer 5.1.5 Others 5.2 Global Angiogenesis Modulators Product Segment by Application 5.2.1 Global Angiogenesis Modulators Sales by Application 5.2.2 Global Angiogenesis Modulators Sales and Market Share by Application (2014-2019) 6 Global Angiogenesis Modulators Market Forecast 6.1 Global Angiogenesis Modulators Sales, Revenue Forecast (2019-2025) 6.1.1 Global Angiogenesis Modulators Sales and Growth Rate Forecast (2019-2025) 6.1.1 Global Angiogenesis Modulators Revenue and Growth Rate Forecast (2019-2025) 6.2 Global Angiogenesis Modulators Forecast by Regions 6.2.1 North America Angiogenesis Modulators Sales and Revenue Forecast (2019-2025) 6.2.2 Europe Angiogenesis Modulators Sales and Revenue Forecast (2019-2025) 6.2.3 Asia-Pacific Angiogenesis Modulators Sales and Revenue Forecast (2019-2025) 6.2.3.1 China 6.2.3.2 Japan 6.2.3.3 Korea 6.2.3.4 Southeast Asia 6.2.3.5 India 6.2.3.6 Australia 6.2.4 South America Angiogenesis Modulators Sales and Revenue Forecast (2019-2025) 6.2.5 Middle East and Africa Angiogenesis Modulators Sales and Revenue Forecast (2019-2025) 6.2.5.1 Egypt 6.2.5.2 GCC Countries 6.3 Angiogenesis Modulators Forecast by Type 6.3.1 Global Angiogenesis Modulators Sales and Revenue Forecast by Type (2019-2025) 6.3.2 Angiogenesis Inhibitors Gowth Forecast 6.3.3 Angiogenesis Stimulators Gowth Forecast 6.4 Angiogenesis Modulators Forecast by Application 6.4.1 Global Angiogenesis Modulators Sales Forecast by Application (2019-2025) 6.4.2 Global Angiogenesis Modulators Forecast in Breast Cancer 6.4.3 Global Angiogenesis Modulators Forecast in Colorectal Cancer 7 Angiogenesis Modulators Upstream Raw Materials 7.1 Angiogenesis Modulators Key Raw Materials 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price 7.1.3 Raw Materials Key Suppliers 7.2 Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Angiogenesis Modulators Industrial Chain Analysis 8 Marketing Strategy Analysis, Distributors 8.1 Marketing Channel 8.1.1 Direct Marketing 8.1.2 Indirect Marketing 8.1.3 Marketing Channel Development Trend 8.2 Distributors 8.3 Downstream Customers 9 Research Findings and Conclusion Appendix Methodology/Research Approach Research Programs/Design Market Size Estimation Market Breakdown and Data Triangulation Data Source Secondary Sources Primary Sources Disclaimer

List of Tables and Figures Figure Angiogenesis Modulators Product Picture Figure Global Angiogenesis Modulators Revenue (Million USD) Status and Outlook (2014-2025) Figure Global Angiogenesis Modulators Sales (K MT) Status and Outlook (2014-2025) Figure Product Picture of Angiogenesis Inhibitors Table Major Players of Angiogenesis Inhibitors Figure Global Angiogenesis Inhibitors Sales (K MT) and Growth Rate (%)(2014-2018) Figure Product Picture of Angiogenesis Stimulators Table Major Players of Angiogenesis Stimulators Figure Global Angiogenesis Stimulators Sales (K MT) and Growth Rate (%)(2014-2019) Figure Product Picture of Angiogenin Table Major Players of Angiogenin Figure Global Angiogenin Sales (K MT) and Growth Rate (%)(2014-2019) Figure Product Picture of Others Table Major Players of Others Figure Global Others Sales (K MT) and Growth Rate (%)(2014-2019) Table Global Angiogenesis Modulators Sales (K MT) and Growth Rate (%) Comparison by Type Table Global Angiogenesis Modulators Sales (K MT) by Type (2014-2019) Table Global Angiogenesis Modulators Sales Share (%) by Type (2014-2019) Figure Global Angiogenesis Modulators Sales Market Share (%) by Type (2014-2019) Figure Global Angiogenesis Modulators Sales Market Share (%) by Type in 2018 Table Global Angiogenesis Modulators Revenue (Million USD) by Type (2014-2019) Table Global Angiogenesis Modulators Revenue Share (%) by Type (2014-2019) Figure Global Angiogenesis Modulators Revenue Share (%) by Type (2014-2019) Figure 2018 Global Angiogenesis Modulators Revenue Market Share (%) by Type Table Global Angiogenesis Modulators Price (USD/MT) by Type (2014-2019) Table Global Angiogenesis Modulators Sales (K MT) by Company (2014-2019) Table Global Angiogenesis Modulators Sales Share (%) by Company (2014-2019) Figure Global Angiogenesis Modulators Sales Share (%) by Company in 2018 Table Global Angiogenesis Modulators Revenue (Million USD) by Company (2014-2019) Table Global Angiogenesis Modulators Revenue Share (%) by Company (2014-2019) Figure Global Angiogenesis Modulators Revenue Share (%) by Company in 2018 Table Global Market Angiogenesis Modulators Average Price (USD/MT) by Company (2014-2019) Table Global Angiogenesis Modulators Top Players Manufacturing Base Distribution and Sales Area Table Global Angiogenesis Modulators Top Players Product Category Figure Global Angiogenesis Modulators Market Share (%) of Top 5 Players Figure Global Angiogenesis Modulators Market Share (%) of Top 10 Players Table Celgene Corporation (USA) Basic Information List Table Celgene Corporation (USA) Angiogenesis Modulators Product Category, Application and Specification Table Celgene Corporation (USA) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure Celgene Corporation (USA) Angiogenesis Modulators Sales Growth Rate (2014-2019) Figure Celgene Corporation (USA) Angiogenesis Modulators Sales Global Market Share (%)(2014-2019) Table Eisai Co., Ltd. (Japan) Basic Information List Figure Eisai Co., Ltd. (Japan) Angiogenesis Modulators Product Category, Application and Specification Table Eisai Co., Ltd. (Japan) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure Eisai Co., Ltd. (Japan) Angiogenesis Modulators Sales Growth Rate (2014-2019) Figure Eisai Co., Ltd. (Japan) Angiogenesis Modulators Sales Global Market Share (%)(2014-2019) Table Amgen, Inc. (USA) Basic Information List Figure Amgen, Inc. (USA) Angiogenesis Modulators Product Category, Application and Specification Table Amgen, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure Amgen, Inc. (USA) Angiogenesis Modulators Sales Growth Rate (2014-2019) Figure Amgen, Inc. (USA) Angiogenesis Modulators Sales Global Market Share (%)(2014-2019) Table Genentech, Inc. (USA) Basic Information List Figure Genentech, Inc. (USA) Angiogenesis Modulators Product Category, Application and Specification Table Genentech, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure Genentech, Inc. (USA) Angiogenesis Modulators Sales Growth Rate (2014-2019) Figure Genentech, Inc. (USA) Angiogenesis Modulators Sales Global Market Share (%)(2014-2019) Table GlaxoSmithKline plc (UK) Basic Information List Figure GlaxoSmithKline plc (UK) Angiogenesis Modulators Product Category, Application and Specification Table GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales Growth Rate (2014-2019) Figure GlaxoSmithKline plc (UK) Angiogenesis Modulators Sales Global Market Share (%)(2014-2019) Table Bayer Pharma AG (Germany) Basic Information List Figure Bayer Pharma AG (Germany) Angiogenesis Modulators Product Category, Application and Specification Table Bayer Pharma AG (Germany) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure Bayer Pharma AG (Germany) Angiogenesis Modulators Sales Growth Rate (2014-2019) Figure Bayer Pharma AG (Germany) Angiogenesis Modulators Sales Global Market Share (%)(2014-2019) Table Bionomics Ltd. (Australia) Basic Information List Figure Bionomics Ltd. (Australia) Angiogenesis Modulators Product Category, Application and Specification Table Bionomics Ltd. (Australia) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure Bionomics Ltd. (Australia) Angiogenesis Modulators Sales Growth Rate (2014-2019) Figure Bionomics Ltd. (Australia) Angiogenesis Modulators Sales Global Market Share (%)(2014-2019) Table CASI Pharmaceuticals, Inc. (USA) Basic Information List Figure CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Product Category, Application and Specification Table CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales Growth Rate (2014-2019) Figure CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Sales Global Market Share (%)(2014-2019) Table AstraZeneca plc (UK) Basic Information List Figure AstraZeneca plc (UK) Angiogenesis Modulators Product Category, Application and Specification Table AstraZeneca plc (UK) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure AstraZeneca plc (UK) Angiogenesis Modulators Sales Growth Rate (2014-2019) Figure AstraZeneca plc (UK) Angiogenesis Modulators Sales Global Market Share (%)(2014-2019) Table Eli Lilly and Company (USA) Basic Information List Figure Eli Lilly and Company (USA) Angiogenesis Modulators Product Category, Application and Specification Table Eli Lilly and Company (USA) Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure Eli Lilly and Company (USA) Angiogenesis Modulators Sales Growth Rate (2014-2019) Figure Eli Lilly and Company (USA) Angiogenesis Modulators Sales Global Market Share (%)(2014-2019) Table F.Hoffmann-La Roche AG (Switzerland) Basic Information List Table Global Angiogenesis Modulators Market Size Comparison by Regions (2014-2025) Figure North America Angiogenesis Modulators Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Asia-Pacific Angiogenesis Modulators Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Europe Angiogenesis Modulators Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure South America Angiogenesis Modulators Revenue (Million USD) and Growth Rate (%)(2014-2025) Figure Middle East and Africa Angiogenesis Modulators Revenue (Million USD) and Growth Rate (%)(2014-2025) Table Global Angiogenesis Modulators Sales (K MT) by Regions (2014-2019) Table Global Angiogenesis Modulators Sales Market Share (%) by Regions (2014-2019) Figure Global Angiogenesis Modulators Sales Market Share (%) by Regions (2014-2019) Figure 2018 Global Angiogenesis Modulators Sales Market Share (%) by Regions Table Global Angiogenesis Modulators Revenue (Million USD) by Regions (2014-2019) Table Global Angiogenesis Modulators Revenue Market Share (%) by Regions (2014-2019) Figure Global Angiogenesis Modulators Revenue Market Share (%) by Regions (2014-2019) Figure 2018 Global Angiogenesis Modulators Revenue Market Share (%) by Regions Table Global Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure North America Angiogenesis Modulators Sales Growth Rate Table North America Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure United States Angiogenesis Modulators Sales (K MT)(2014-2019) Figure United States Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure Canada Angiogenesis Modulators Sales (K MT)(2014-2019) Figure Canada Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure Mexico Angiogenesis Modulators Sales (K MT)(2014-2019) Figure Mexico Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure Europe Angiogenesis Modulators Sales Growth Rate Table Europe Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure Germany Angiogenesis Modulators Sales (K MT)(2014-2019) Figure Germany Angiogenesis Modulators Revenue (Million USD) (2014-2019) Figure UK Angiogenesis Modulators Sales (K MT)(2014-2019) Figure UK Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure France Angiogenesis Modulators Sales (K MT)(2014-2019) Figure France Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure Italy Angiogenesis Modulators Sales (K MT)(2014-2019) Figure Italy Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure Russia Angiogenesis Modulators Sales (K MT)(2014-2019) Figure Russia Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure Turkey Angiogenesis Modulators Sales (K MT)(2014-2019) Figure Turkey Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure Asia-Pacific Angiogenesis Modulators Sales Growth Rate Table Asia-Pacific Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure China Angiogenesis Modulators Sales (K MT)(2014-2019) Figure China Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure Japan Angiogenesis Modulators Sales (K MT)(2014-2019) Figure Japan Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure Korea Angiogenesis Modulators Sales (K MT)(2014-2019) Figure Korea Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure Southeast Asia Angiogenesis Modulators Sales (K MT)(2014-2019) Figure Southeast Asia Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure Indonesia Angiogenesis Modulators Sales (K MT)(2014-2019) Figure Indonesia Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure Thailand Angiogenesis Modulators Sales (K MT)(2014-2019) Figure Thailand Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure Malaysia Angiogenesis Modulators Sales (K MT)(2014-2019) Figure Malaysia Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure Philippines Angiogenesis Modulators Sales (K MT)(2014-2019) Figure Philippines Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure Vietnam Angiogenesis Modulators Sales (K MT)(2014-2019) Figure Vietnam Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure India Angiogenesis Modulators Sales (K MT)(2014-2019) Figure India Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure Australia Angiogenesis Modulators Sales (K MT)(2014-2019) Figure Australia Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure South America Angiogenesis Modulators Sales Growth Rate Table South America Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure Brazil Angiogenesis Modulators Sales (K MT)(2014-2019) Figure Brazil Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure Middle East and Africa Angiogenesis Modulators Sales Growth Rate Table Middle East and Africa Angiogenesis Modulators Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2014-2019) Figure North Africa Angiogenesis Modulators Sales (K MT)(2014-2019) Figure North Africa Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure GCC Countries Angiogenesis Modulators Sales (K MT)(2014-2019) Figure GCC Countries Angiogenesis Modulators Revenue (Million USD)(2014-2019) Figure Breast Cancer Examples Figure Colorectal Cancer Examples Figure Lung Cancer Examples Figure Prostate Cancer Examples Figure Others Examples Table Global Angiogenesis Modulators Sales (K MT) Comparison by Application (2014-2025) Table Global Angiogenesis Modulators Sales (K MT) by Application (2014-2019) Table Global Angiogenesis Modulators Sales Share (%) by Application (2014-2019) Figure Global Angiogenesis Modulators Sales Market Share (%) by Application (2014-2019) Figure Global Angiogenesis Modulators Sales Market Share (%) by Application in 2018 Figure Global Angiogenesis Modulators Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure Global Angiogenesis Modulators Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025) Table Global Angiogenesis Modulators Sales (K MT) Forecast by Regions (2019-2025) Figure Global Angiogenesis Modulators Sales Market Share (%) Forecast by Regions (2019-2025) Figure North America Angiogenesis Modulators Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure North America Angiogenesis Modulators Revenue and Growth Rate (%) Forecast (2019-2025) Figure Europe Angiogenesis Modulators Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure Europe Angiogenesis Modulators Revenue and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Angiogenesis Modulators Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure Asia-Pacific Angiogenesis Modulators Revenue and Growth Rate (%) Forecast (2019-2025) Figure China Angiogenesis Modulators Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure China Angiogenesis Modulators Revenue and Growth Rate (%) Forecast (2019-2025) Figure Japan Angiogenesis Modulators Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure Japan Angiogenesis Modulators Revenue and Growth Rate (%) Forecast (2019-2025) Figure Korea Angiogenesis Modulators Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure Korea Angiogenesis Modulators Revenue and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Angiogenesis Modulators Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure Southeast Asia Angiogenesis Modulators Revenue and Growth Rate (%) Forecast (2019-2025) Figure India Angiogenesis Modulators Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure India Angiogenesis Modulators Revenue and Growth Rate (%) Forecast (2019-2025) Figure Australia Angiogenesis Modulators Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure Australia Angiogenesis Modulators Revenue and Growth Rate (%) Forecast (2019-2025) Figure South America Angiogenesis Modulators Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure South America Angiogenesis Modulators Revenue and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Angiogenesis Modulators Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure Middle East and Africa Angiogenesis Modulators Revenue and Growth Rate (%) Forecast (2019-2025) Figure North Africa Angiogenesis Modulators Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure North Africa Angiogenesis Modulators Revenue and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Angiogenesis Modulators Sales (K MT) and Growth Rate (%) Forecast (2019-2025) Figure GCC Countries Angiogenesis Modulators Revenue and Growth Rate (%) Forecast (2019-2025) Table Global Angiogenesis Modulators Sales (Million USD) Forecast by Type (2019-2025) Figure Global Angiogenesis Modulators Sales Market Share (%) Forecast by Type (2019-2025) Table Global Angiogenesis Modulators Revenue (Million USD) Forecast by Type (2019-2025) Figure Global Angiogenesis Modulators Revenue Market Share (%) Forecast by Type (2019-2025) Figure Angiogenesis Inhibitors Sales Growth Forecast Figure Angiogenesis Stimulators Sales Growth Forecast Table Global Angiogenesis Modulators Sales (K MT) Forecast by Application (2019-2025) Figure Global Angiogenesis Modulators Sales Forecast by Application (2019-2025) Figure Global Angiogenesis Modulators Sales (K MT) Forecast in Breast Cancer Figure Global Angiogenesis Modulators Sales (K MT) Forecast in Colorectal Cancer Table Key Raw Materials Lists Figure Key Raw Materials Price Table Raw Materials Key Suppliers Lists Figure Angiogenesis Modulators Manufacturing Cost Structure Figure Angiogenesis Modulators Industrial Chain Analysis Table Distributors List Table Angiogenesis Modulators Downstream Customers

Celgene Corporation (USA) Eisai Co., Ltd. (Japan) Amgen, Inc. (USA) Genentech, Inc. (USA) GlaxoSmithKline plc (UK) Bayer Pharma AG (Germany) Bionomics Ltd. (Australia) CASI Pharmaceuticals, Inc. (USA) AstraZeneca plc (UK) Eli Lilly and Company (USA) F.Hoffmann-La Roche AG (Switzerland)